This is the authors' abstract. We don't add key points for this paper.
Nonpathogenic bacteria coats filled with complex metal nanoparticles form multifunctional magnetic nanoparticles (MNPs) for targeting cancer tumors. The encapsulated metal nanoparticles along with anticancer drugs inside polymer or bacterial coats become physiologically tumor sensitive due to hysteresis and pH sensitivity and drug active covalent bonds. Drug-bearing bacterial and polymer nanoshells open and close at specific pH to release anticancer drugs in controlled manner at the tumor sites. Simultaneously, metal core generates multimodal images. Such combined effect of chemotherapy and tumor sensitive nanodrugs offers hybrid approach of an effective and minimal invasive protocol of tumor management. Delivery of nanoshells filled with drug and nanometal core at tumor targets, offers theranostic monitoring of cancer prevention. Presence of metal in the core of nanoshells also serves as a non-invasive imaging contrast agent for therapeutic and diagnostic monitoring to evaluate the success of cancer prevention in real time. Preliminary opinion reported in Nature Precedings, hdl:10101/ npre.2008.2190.1 suggested significant tumor relapse or reduced dose dependent neoplastic progress of tumor as possible mode of tumor management by real-time tumor imaging.to prolong the life. Nanoparticles made of drug conjugates and complexes, dendrimers, vesicles, micelles, core-shell particles, microbubbles, and carbon nanotubes also function as smart imaging contrast to visually monitor the tumor tissue behavior and functions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rakesh Sharma (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: